| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |